JP2019532631A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019532631A5 JP2019532631A5 JP2019515292A JP2019515292A JP2019532631A5 JP 2019532631 A5 JP2019532631 A5 JP 2019532631A5 JP 2019515292 A JP2019515292 A JP 2019515292A JP 2019515292 A JP2019515292 A JP 2019515292A JP 2019532631 A5 JP2019532631 A5 JP 2019532631A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- seq
- peptide
- tumor
- modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022197406A JP2023029997A (ja) | 2016-09-27 | 2022-12-09 | エンベロープウイルスの非遺伝的改変 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1616365.1A GB201616365D0 (en) | 2016-09-27 | 2016-09-27 | Non-genetic modification of enveloped viruses |
| GB1616365.1 | 2016-09-27 | ||
| PCT/EP2017/072366 WO2018059896A1 (en) | 2016-09-27 | 2017-09-06 | Non-genetic modification of enveloped viruses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022197406A Division JP2023029997A (ja) | 2016-09-27 | 2022-12-09 | エンベロープウイルスの非遺伝的改変 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019532631A JP2019532631A (ja) | 2019-11-14 |
| JP2019532631A5 true JP2019532631A5 (cg-RX-API-DMAC7.html) | 2020-10-08 |
| JP7258746B2 JP7258746B2 (ja) | 2023-04-17 |
Family
ID=57539741
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019515292A Active JP7258746B2 (ja) | 2016-09-27 | 2017-09-06 | エンベロープウイルスの非遺伝的改変 |
| JP2022197406A Pending JP2023029997A (ja) | 2016-09-27 | 2022-12-09 | エンベロープウイルスの非遺伝的改変 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022197406A Pending JP2023029997A (ja) | 2016-09-27 | 2022-12-09 | エンベロープウイルスの非遺伝的改変 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10982194B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3519565A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7258746B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102599401B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109890957A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2017337753B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019005825A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3035104A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201616365D0 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2760521C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018059896A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201902388B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201907413D0 (en) * | 2019-05-24 | 2019-07-10 | Univ Helsinki | Viral vector |
| EP3982980A4 (en) * | 2019-06-12 | 2023-11-29 | BioNTech US Inc. | NEOANTIGEN COMPOSITIONS AND USES THEREOF |
| CA3152796A1 (en) * | 2019-08-27 | 2021-03-04 | Turnstone Biologics Corp. | Methods for inducing an immune response against neoantigens |
| GB202013834D0 (en) * | 2020-09-03 | 2020-10-21 | Valo Therapeutics Oy | PeptiVAX therapy |
| AU2023367780A1 (en) | 2022-10-25 | 2025-03-27 | Barinthus Biotherapeutics North America, Inc. | Self-assembling nanoparticles |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1108047A1 (en) | 1998-08-27 | 2001-06-20 | Aventis Pharma S.A. | Targeted adenovirus vectors for delivery of heterologous genes |
| MXPA01005389A (es) * | 1998-11-30 | 2003-03-27 | Cytos Biotechnology Ag | Presentacion molecular ordenada de antigenos, metodos de preparacion y uso. |
| CN1477964A (zh) * | 1999-04-15 | 2004-02-25 | 应用病毒治疗肿瘤 | |
| KR100773109B1 (ko) | 1999-05-06 | 2007-11-02 | 웨이크 포리스트 유니버시티 | 면역 반응을 유발하는 항원을 동정하기 위한 조성물과 방법 |
| CA2390081C (en) * | 1999-10-29 | 2011-07-05 | University Of Southern California | Modified viral surface proteins which bind to cells of tumor vasculature |
| MXPA04005382A (es) * | 2001-11-07 | 2005-02-24 | Mannkind Corp | Vectores de expresion que codifican epitopes de antigenos asociados al objetivo y metodos para su diseno. |
| GB0203285D0 (en) * | 2002-02-12 | 2002-03-27 | Brown Susanne M | An herpes simplex virus complex |
| WO2004000220A2 (en) | 2002-06-21 | 2003-12-31 | Genetix Pharmaceuticals, Inc. | Methods for purifying viral particles for gene therapy |
| US20070243170A1 (en) * | 2002-10-07 | 2007-10-18 | The University Of Chicago | Targeting of Herpes Simplex Virus to Specific Receptors |
| CN101675993A (zh) * | 2003-03-26 | 2010-03-24 | 赛托斯生物技术公司 | Melan-a肽类似物-病毒样颗粒偶联物 |
| HRP20120845T1 (hr) * | 2003-07-02 | 2012-11-30 | Innate Pharma | Protutijela za pan-kir2dl nk-receptor i njihova uporaba u dijagnostici i lijeäśenju |
| US7432045B2 (en) * | 2003-12-01 | 2008-10-07 | Wisconsin Alumni Research Foundation | Method of inhibiting influenza infection with antiviral peptides |
| SG149013A1 (en) * | 2003-12-17 | 2009-01-29 | Wyeth Corp | Immunogenic peptide carrier conjugates and methods of producing same |
| EP1921149A1 (en) * | 2006-11-13 | 2008-05-14 | AEterna Zentaris GmbH | Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof |
| JP2008136381A (ja) * | 2006-11-30 | 2008-06-19 | Japan Health Science Foundation | 改変型アデノウイルスベクター及びその作製方法 |
| WO2009117656A2 (en) | 2008-03-21 | 2009-09-24 | Vectorlogics,Inc. | Capsid-incorporated antigen for novel adenovirus vaccine |
| NO2700405T3 (cg-RX-API-DMAC7.html) * | 2008-05-29 | 2018-09-01 | ||
| US10603351B2 (en) * | 2008-08-21 | 2020-03-31 | Turnstone Limited Partnership | Engineered synergistic oncolytic viral symbiosis |
| ES2335077B1 (es) | 2008-12-30 | 2011-02-02 | Instituto Aragones De Ciencias De La Salud | Formulaciones para el recubrimiento y transporte de diversos elementos hacia los tumores. |
| SG176554A1 (en) * | 2009-05-12 | 2012-01-30 | Transgene Sa | Method for orthopoxvirus production and purification |
| RU2013118723A (ru) | 2010-09-24 | 2014-10-27 | Онкос Терапьютикс Ой | Онколитические аденовирусные векторы, кодирующие моноклональные антитела против ctla-4 |
| US20140140962A1 (en) | 2011-04-29 | 2014-05-22 | The Research Foundation Of State University Of New York | Viruses modified with unnatural moieties and methods of use thereof |
| US20140349944A1 (en) * | 2013-05-23 | 2014-11-27 | Musc Foundation For Research Development | Chaperone-based integrin inhibitors for the treatment of cancer and inflammatory diseases |
| ES2847305T3 (es) * | 2013-08-22 | 2021-08-02 | Univ Pittsburgh Commonwealth Sys Higher Education | Terapias inmunooncolíticas |
| DK3184641T3 (da) * | 2013-10-28 | 2020-08-03 | Univ Of Pittsburgh - Of The Commonwealth System Of Higher Education | Onkolytisk hsv-vektor |
| JP6705755B2 (ja) | 2014-05-19 | 2020-06-03 | バロ セラピューティクス オイValo Therapeutics Oy | 癌ワクチン開発のための改変アデノウイルス |
-
2016
- 2016-09-27 GB GBGB1616365.1A patent/GB201616365D0/en not_active Ceased
-
2017
- 2017-09-06 AU AU2017337753A patent/AU2017337753B2/en active Active
- 2017-09-06 JP JP2019515292A patent/JP7258746B2/ja active Active
- 2017-09-06 CN CN201780056649.7A patent/CN109890957A/zh active Pending
- 2017-09-06 BR BR112019005825-7A patent/BR112019005825A2/pt not_active Application Discontinuation
- 2017-09-06 KR KR1020197012062A patent/KR102599401B1/ko active Active
- 2017-09-06 WO PCT/EP2017/072366 patent/WO2018059896A1/en not_active Ceased
- 2017-09-06 RU RU2019110407A patent/RU2760521C2/ru active
- 2017-09-06 US US16/337,220 patent/US10982194B2/en active Active
- 2017-09-06 CA CA3035104A patent/CA3035104A1/en active Pending
- 2017-09-06 EP EP17765150.2A patent/EP3519565A1/en active Pending
-
2019
- 2019-04-15 ZA ZA2019/02388A patent/ZA201902388B/en unknown
-
2022
- 2022-12-09 JP JP2022197406A patent/JP2023029997A/ja active Pending
-
2023
- 2023-09-29 AU AU2023237201A patent/AU2023237201B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124275T1 (el) | Vsv/ndv υβριδικοι ιοι για την ογκολυτικη θεραπεια του καρκινου | |
| Zamarin et al. | Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions | |
| Swiecki et al. | BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor | |
| JP2017522025A5 (cg-RX-API-DMAC7.html) | ||
| JP2019513118A5 (cg-RX-API-DMAC7.html) | ||
| US20210169956A1 (en) | Increased activity of oncolytic newcastle disease virus | |
| RU2019110407A (ru) | Негенетическая модификация оболочечных вирусов | |
| JP2019526580A5 (cg-RX-API-DMAC7.html) | ||
| JP2019501671A5 (cg-RX-API-DMAC7.html) | ||
| RU2017103162A (ru) | Онколитический вирус для экспрессии модуляторов иммунологических контрольных точек | |
| JP2019508045A5 (cg-RX-API-DMAC7.html) | ||
| JP2010523471A5 (cg-RX-API-DMAC7.html) | ||
| JP2005521398A5 (cg-RX-API-DMAC7.html) | ||
| US10604741B2 (en) | Compositions and methods for enhancing virus replication | |
| JP2023542297A5 (cg-RX-API-DMAC7.html) | ||
| JP2020533411A5 (cg-RX-API-DMAC7.html) | ||
| TW202227126A (zh) | 異源初免加強疫苗 | |
| FI3448879T3 (fi) | Claudin-6 -peptidejä | |
| JP2023529839A5 (cg-RX-API-DMAC7.html) | ||
| JP2023536466A5 (cg-RX-API-DMAC7.html) | ||
| Parzych et al. | Influenza virus specific CD8+ T cells exacerbate infection following high dose influenza challenge of aged mice | |
| JP2024534189A5 (cg-RX-API-DMAC7.html) | ||
| JP2024523329A5 (cg-RX-API-DMAC7.html) | ||
| RU2011120447A (ru) | Эпитопные пептиды rab6kifl/kif20a и содержащие их вакцины | |
| CN109890839A (zh) | 识别sage1抗原短肽的t细胞受体 |